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Abstract
Congenital hypothyroidism strongly affects myelination. To as-
sess the role of thyroid hormone on myelin gene expression, we
have studied the effect of hypothyroidism on the steady state
levels of myelin-associated glycoprotein (MAG) and its
mRNA in rat brain during the first postnatal month. As studied
by immunoblot analysis of several brain regions, MAG in-
creased from days 10-15 onwards, reaching constant levels by
days 20-25. Hypothyroid samples showed a delay in the accu-
mulation ofMAG that was more severe in rostral regions, such
as cortex and hippocampus. The effect of hypothyroidism on
the accumulation of the protein correlated with mRNA levels.
MAG mRNA started to accumulate in the cerebrum of normal
animals by postnatal day 7, reaching maximal levels by day 20.
Hypothyroid rats showed a delay of several days in the onset of
mRNA expression, increasing thereafter at the same rate as in
normal animals, and eventually reaching similar values. When
individual brain regions were analyzed, we found strong re-
gional differences in the effect of hypothyroidism. The cerebral
cortex was most affected, with messenger levels lower than in
normal animals at all ages. In more caudal regions differences
between control and hypothyroid rats were evident only at the
earlier stages of myelination, with spontaneous recovery at
later ages. By run on analysis, we found no differences in tran-
scriptional activities of the MAG gene in normal, hypothyroid,
or T4-treated rats. Therefore, the effects of hypothyroidism on
MAG mRNA and protein levels were most likely caused by
decreased mRNA stability. We propose that thyroid hormone
contributes to enhanced myelin gene expression by affecting
the stability of newly transcribed mRNA in the early phases of
myelination. (J. Clin. Invest. 1993.812-818.) Key words: mye-
lination * development * cretinism * oligodendrocytes - mRNA
stabilization
Introduction
Among the most dramatic and less understood actions of thy-
roid hormones are those exerted on brain development. Con-
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genital hypothyroidism in the human being may lead to mental
deficiency and other neurological abnormalities. In experimen-
tal animals such as the rat, the deleterious effects of thyroid
hormone deprivation during the fetal and neonatal periods on
brain maturation have also been extensively documented (for
reviews, see references 1-4).
The molecular basis of thyroid hormone action on the
brain remain largely ignored. The physiological effects of thy-
roid hormone are the end result of the regulation of a series of
specific genes (5, 6) mediated through receptors of the erbA
family of nuclear proteins acting as ligand-dependent tran-
scription factors (5-9). Both receptor binding activity and the
mRNAs coding for two of the three known forms of thyroid
hormone receptor, namely a- 1 and 3-1 c- erbAs have been dem-
onstrated in rat brain, and a specific temporal and regional
distribution pattern has been described by hybridization histo-
chemistry in adult and developing animals ( 10, 11). Therefore
it is likely that the brain effects of thyroid hormone, as in other
organs, are also caused by the control of expression of specific
brain genes. However, until recently, no genes expressed in the
nervous system have been shown to be regulated at the pre-
translational level by thyroid hormone ( 12). In particular, de-
spite the known effects of thyroid hormone on myelination
( 1-4, 13-18), there are few data on the role and mechanism of
thyroid hormone action in the regulation of myelin gene ex-
pression in vivo. Our laboratory has recently shown that genes
encoding myelin proteins are affected by hypothyroidism at
the pretranslational level ( 12). For one of the abundant struc-
tural proteins of myelin, the basic protein (MBP),' thyroid
hormone has been proposed to act at the transcriptional ( 19),
or posttranscriptional levels (20).
Myelin is a multilamelar membrane structure surrounding
many axons in the central and peripheral nervous system (21-
24). Central myelin is produced by differentiated oligodendro-
cytes and consists mainly of lipids (75%) and proteins (25%).
A minor component of these proteins is myelin-associated gly-
coprotein (MAG), which comprises -1% of central myelin
proteins, and is present in periaxonal membranes of uncom-
pacted myelin. MAG is a member of the immunoglobulin su-
perfamily, with strong homologies with cell adhesion mole-
cules such as N-CAM, L l (Ng-CAM), and J l (21, 25, 26). In
hypomyelinating mutant mice (quaking), a splicing defect of
the MAG gene has been found (27), and direct proof that
binding of oligodendrocytes to neurons is mediated by MAG
has been obtained (28). From its cell adhesion properties, the
early expression ofMAG is proposed to play a critical role in
myelination, by establishing homotypic interactions among
1. Abbreviations used in this paper: MAG, myelin-associated glycopro-
tein; MBP, myelin basic protein; MMI, methylmercaptoimidazol; P5,
postnatal day 5.
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oligodendrocytes, or heterotypic interactions between oligo-
dendrocytes and neurons (25, 26).
In view of the likely important role of MAG expression in
the initial steps of myelination, we have studied the temporal
pattern ofMAG gene expression during the neonatal period in
normal and hypothyroid rats. We find that in the absence of
thyroid hormone, as occurs in neonatal hypothyroidism, the
accumulation of MAG mRNA in the brain is delayed several
days leading to a transient decrease ofMAG mRNA and pro-
tein in most brain regions examined. The results suggest that
thyroid hormones are needed for the timely expression of
MAG acting at a posttranscriptional level. Among other possi-
bilities, it is likely that thyroid hormone act by stabilizing newly
transcribed MAG mRNA during the early phases of myelina-
tion.
Methods
Handling of animals and measurement of thyroid hormones. Wistar
rats raised in our animal facilities have been used throughout these
studies. To induce fetal and neonatal hypothyroidism, drinking water
containing 0.02% methylmercaptoimidazol (MMI) was administered
to pregnant rats starting from the 9th d after conception and was con-
tinued until the end ofthe experiments. In addition to MMI treatment,
and to ensure cerebral hypothyroidism, the neonates were surgically
thyroidectomized on postnatal day 5 (P5).
Thyroid hormones were measured in individual cortices of normal
and hypothyroid rats on P5 and P20. On P5, hypothyroidism was
caused by MMI treatment only, as described above, whereas on P20,
hypothyroidism was the combined result ofMMI treatment plus surgi-
cal thyroidectomy performed 15 d before. Tissue extraction and radio-
immunoassay procedures were as described by Morreale de Escobar et
al. (29).
Immunoblots. MAG protein abundance was estimated as follows:
brain tissue was homogenized in the cold in 4 vol of PBS. To 0.5-ml
aliquots ofthe homogenates was added 0.5 ml ofSDS extraction buffer
(0.125 M Tris-HCl, pH 6.8, 4.6% SDS, and 10% beta mercaptoeth-
anol), and the mixture was vortexed vigorously, boiled for 2 min, and
centrifuged in an Eppendorf centrifuge for 5 min. Aliquots of the su-
pernatants containing 10 jg of protein were electrophoresed in 7.5%
polyacrylamide gels by the Laemli method, and transferred to nitrocel-
lulose using a semidry transfer apparatus (Pharmacia LKB Biotechnol-
ogy Inc., Piscataway, NJ) at 1 mA/cm2 for 90 min. The filters were
washed and blocked with blotto (5% skimmed milk in PBS). The poly-
clonal MAG antibody, P5, directed against the COOH-terminal por-
tion of clone lB235/MAG (25) was a gift of Dr J. G. Sutcliffe (Re-
search Institute ofScripps Clinic, La Jolla, CA). The antibody was used
at 1:5,000 dilution. For the color reaction we used the alkaline phos-
phatase kit from Promega (Madison, WI) following the manufacturer's
instruction.
Slot and Northern blots. Total RNA was prepared (30) from differ-
ent brain regions at different times during postnatal development and
poly(A)+ RNA was further purified after oligo(dT) cellulose chroma-
tography (3 1 ). Slot and Northern blots were performed on nylon (Ny-
tran; Schleicher & Schuell, Inc., Keene, NH). For slot blotting, 1, 2,
and 3 ,ug of poly(A)+ RNA were applied to the filters using a slot blot
apparatus Bio Rad Laboratories Inc., Hercules, CA). Samples were
treated as described (32). For Northern blots, 20 ,g of total RNA was
fractionated on formaldehyde-agarose gels and transferred to the filters
using standard techniques (32). RNA concentrations in the samples
were measured by absorbance at 260 nm, and an aliquot of the RNA
preparation was electrophoresed in agarose minigels and visualized by
ethidium bromide staining to control for RNA integrity. After transfer,
the nylon filters were stained with methylene blue (33). The intensity
of stained 18S and 28S ribosomal RNAs gave a direct comparison of
the relative amounts ofRNA applied to the gels. In some experiments,
and to further control for integrity and amount ofRNA present in the
filters, these were hybridized with a cDNA probe encoding cyclophilin.
Cyclophilin mRNA levels are constant in the brain during develop-
ment (34) and thyroid manipulations have no effect ( 12). Filters were
hybridized at 420C in 3 X SSC ( 1 X SSC = 0.15 M NaCl, 0.015 M Na
citrate), 5 X Denhardt's solution (1 x Denhardt's solution = 0.1%
Ficoll, 0.1% polyvinylpirrolidone, 0.1% BSA) and 50% formamide for
20 h, and washed at 650C in 0.2 x SSC, 0.5% SDS, before exposure on
x-ray films.
As a probe, we used the MAG clone 1B236-18 (25) containing the
full-length rat cDNA; labeling was by either the random priming
method or by nick translation following standard techniques (32).
[32P]dCTP (sp act > 3,000 Ci/mmol; from New England Nuclear,
Boston, MA, or Amersham Corp., Arlington Heights, IL) was used for
the labeling reactions. Specific activities ofthe radioactive probes were
above 108 dpm//Ag DNA.
Run-on assays. To measure the transcriptional activity ofthe MAG
gene under different thyroidal status, we isolated cell nuclei from cere-
bral corteces or whole cerebra of normal, hypothyroid, and T4-treated
hypothyroid rats. Nuclei were isolated after homogenizing the tissues
in 0.25 M sucrose, 1 mM MgC12, 1 mM CaC12, 10 mM Tris-HCl, pH
7.4, containing 0.5% NP-40 (Sigma Chemical Co., St. Louis, MO)
using a Dounce homogenizer at 0C. Run-on reactions were per-
formed basically according to (35) using [a- 32p]UTP and nuclei equiv-
alent to 100 ,ug of DNA. The probes were 5 ,g of linearized MAG or
cyclophilin plasmid DNA immobilized on nitrocellulose filters after
denaturation in NaOH. Linearized pBR322 was also present on the
filters to control for background hybridization. Labeled RNA was puri-
fied by phenol/chloroform extraction after addition of 3 vol of guani-
dine isothiocyanate solution (30) and isopropanol precipitation. Unin-
corporated label was removed by centrifugation through Sephadex
G-50 spun columns. Recovery as high molecular weight material from
the columns was 7% of the total radioactivity present in the run-on
reactions. Hybridizations were performed in 0.2 M sodium phosphate
buffer, pH 7.2, 1 mM EDTA, 7% SDS, and 45% formamide containing
250 ,g/ ml Escherichia coli transfer RNA as a carrier, at 50°C for 2 d.
After hybridization the filters were washed in 40 mM sodium phos-
phate buffer, pH 7.2, containing 1% SDS at 65°C. Control of MAG
RNA hybridization to the immobilized cDNA on the filters was carried
out by including a 3H-labeled MAG mRNA. This was synthesized by
transcribing a full-length MAG cDNA template cloned in pGEM4 with
SP6 polymerase in the presence of [3H]UTP using standard methods
(32). Synthesis ofthe transcript was assessed by TCA precipitation and
agar gel electrophoresis. 50,000 cpm of the tritiated MAG mRNA was
mixed with the 32P-labeled RNA from each experimental group before
adding to the filters. After hybridization and washing, the filters were
exposed to x-ray films, and the bands were cut out to measure 32p
and 3H.
Statistical analysis. Data from MAG mRNA abundance as mea-
sured by slot blots were submitted to two-way analysis of variance.
Significance of differences between groups was assessed using the pro-
tected least significance differences test, and considered significant
when P < 0.05. All these calculations were performed as described by
Snedecor and Cochran (36).
Results
T4 and T3 concentrations in the cerebral cortex ofnormal and
hypothyroid rats. To determine whether our protocol for in-
ducing cerebral hypothyroidism resulted in low concentrations
of thyroid hormones, we determined T4 and T3 concentra-
tions by RIA in ethanolic extracts of total cerebral cortex from
normal and hypothyroid rats killed at 5 and 20 d of age. T4 and
T3 determinations were performed in the cerebral cortex, since
T4 5'-deiodinase is abundant in this part of the brain, and its
activity increases in hypothyroid animals (37). Therefore,
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brain T3 levels may be normal even ifplasma and other tissues
show low levels ofthe hormone. Fig. 1 shows that T4 increased
in normal animals from 0.9 ng/g on P5 to 2 ng/g on P20 (P
< 0.001). After MMI treatment to the dams from the 9th d
after conception, T4 levels in the cerebral cortex of the off-
springs 5 d after birth was 0.1 ng/g. T4 increased in hypothy-
roid, P20 animals, but its concentration was still only 0.2 ng/g;
i.e., 10-fold lower than in normal animals of the same age. T3
concentrations increased in normal animals from 3.2 to 3.8
ng/g (P < 0.01) from P5 to P20. In hypothyroid animals, T3
concentrations were 0.14 and 0.21 ng/g, respectively. These
results demonstrate that the combined treatment of chemical
and surgical thyroidectomy ensured low tissue levels ofT4 and
T3 throughout the developmental period studied.
Developmental expression ofMAG mRNA. The expression
of the MAG gene during development was studied in slot blots
ofpoly(A)' RNA samples isolated from cerebra ofnormal and
hypothyroid animals at different times after birth. 1-, 2-, and
3-,gg aliquots of RNA obtained from individual rats were ap-
plied to the filters, which were hybridized with a MAG cDNA
probe. Fig. 2 shows densitometric measurements of the corre-
sponding signals in the radioautograms from individual ani-
mals. MAG mRNA was not detected during the first 5-7 d
after birth. In normal animals, it increased in abundance, there-
after reaching maximal levels around day 20. In hypothyroid
animals, MAG mRNA accumulation in total brain also in-
creased with age, but more slowly and with an apparent delay
when compared with normal animals. The data points were
computer-fitted to generate the curves depicted, with signifi-
cance levels ofP < 0.01 for the control curve, and P < 0.001 for
the hypothyroid curve. Two-way analysis of variance taking as
factors age and thyroid status, indicated that as a whole the data
from hypothyroid animals were different from the controls (F
ratio = 9.0, P = 0.008). When individual time points were
considered, there were no significant differences between hypo-
thyroid and control values beyond 20 d of age, when the
plateau of MAG mRNA was attained.
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Figure 2. Developmental pattern ofMAG mRNA expression in nor-
mal and hypothyroid rats. MAG mRNA was measured in slot blots
using poly(A)+ RNA purified from whole cerebra of normal (black
squares and solid line) and hypothyroid (open dots and dotted line)
animals. The data represented are individual values, or mean±SD of
data from three different animals.
Temporal and regional effects ofhypothyroidism on MAG
gene expression. The results described above suggest that a ma-
jor effect ofhypothyroidism on MAG gene expression is a tran-
sient delay in the normal developmental pattern. However,
myelination has not the same timing in all brain regions, pro-
ceeding normally from caudal to rostral areas (38). In other
words, in the above experiment, we examined a mixture of
widely heterogeneous regions at different stages of myelina-
tion. Therefore, we examined the effect of hypothyroidism on
the regional pattern of expression of the MAG gene during the
first month of life. Brains from normal and hypothyroid ani-
mals were individually dissected into regions including cere-
bral cortex, striatum, hippocampus, mesencephalon, and hypo-
thalamus. RNA was isolated from individual cortices or from
pooled regions as described, and the mRNA encoding MAG,
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Figure 1. T4 and T3 concentrations in the cerebral cortices of normal
and hypothyroid rats. T4 and T3 were measured by radioimmunoas-
say in extracts from the cerebral cortices of normal (solid bars) and
hypothyroid (hatched bars) rats at 5 and 20 d after birth. Differences
between normal and hypothyroid animals were statistically signifi-
cant, with P < 0.001.
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Figure 3. Effect of hypothyroidism on MAG mRNA abundance in
the cerebral cortex. Total RNA was purified from individual cortices
at 10, 20, and 30 d (experiment A) or at 20 and 25 d (experiment B)
after birth, and analyzed by Northern blotting using a labeled MAG
cDNA as a probe. The filter was rehybridized with a probe for cyclo-
philin, an ubiquitous mRNA unaffected by hypothyroidism ( 12), and
the ratio MAG to cyclophilin was measured. In experiment A, we
processed three individual samples from each group, and the data are
mean±SD ofthree values. MAG mRNA was not detected on day 10
(ND). In experiment B, we analyzed pools oftwo samples from either
normal or hypothyroid animals.
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was identified by Northern blotting. Fig. 3 shows the results
obtained using cerebral cortices of normal and hypothyroid
rats of different ages. (The rat cerebral cortex contains an esti-
mated 1.1 million callosal fibers, from which about two thirds
are myelinated. (38a) These fibers enter the cortical plate
around day 3 after birth, and the adult pattern is attained at the
end ofthe 1st wk oflife. In our experiments, cortex MAG arises
from the cortex proper and from the subcortical white matter.)
Two different sets of data are represented in the figure. Data
labeled A are the mean±SD of three individual cortices from
each age group. Data labeled B are single determinations from
pools of two different cortices. Results in each case are very
similar. The MAG mRNA bands were quantified by densitom-
etry after Northern blotting and related to the intensity of a
cyclophilin mRNA control. On day, 1O little MAG mRNA was
present in normal cortex, and it was undetectable in the cortex
of hypothyroid animals. At any subsequent time, hypothyroid
levels were reduced by - 80% or more compared to normal
values.
Fig. 4 shows Northern blot patterns ofMAG mRNA in four
different regions of the brain from normal controls (C) and
hypothyroid (H) rats throughout the first month of life, at 5,
10, 15, 20, and 30 d of age. Pools of three samples were pro-
cessed in these experiments. The results show that the effect of
hypothyroidism depends on the region examined and the age
of the animals. In the hippocampus, maximal amounts of
MAG mRNA were attained at around 25 d of age in normal
animals. In hypothyroid animals, however, lower levels were
found at all ages, and by 25 d, normal amounts were not yet
attained. In contrast to the cortex and hippocampus, the effect
of hypothyroidism in the striatum, mesencephalon, and hypo-
thalamus was evident only at the earliest stages of myelination,
from the 10th to the 15th postnatal days.
Patterns ofMAG expression in normal and hypothyroid
animals. Fig. 5 shows the results ofMAG expression in immu-
noblots of different regions of normal and hypothyroid brains.
Different ages along the neonatal period are represented in the
figure. The P5 antibody used for the immunoblots detected a
main 100-1 16 kD protein band that was not present in the
brain before myelination. This band was not detected in con-
trol experiments using extracts from other organs such as liver
or kidney (not shown). The blots were overdeveloped to in-
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Figure 4. Developmental pattern of MAG mRNA in brain regions.
Total RNA was purified from pooled (three samples for each pool)
regions individually dissected from the brains of normal (C) and hy-
pothyroid (H) rats at different days after birth. After transfer the ny-
lon filters were stained to visualize ribosomal RNA to control for in-
tegrity and amount ofRNA present in each lane (not shown). The
lanes contained similar amounts of RNA, except for C 15 and H 15 in
the striatum, which contained lower and higher amounts, respec-
tively, and H15 in the hypothalamus that contained much lower
amount of RNA than calculated.
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Figure 5. Developmental pattern ofMAG in normal and hypothyroid
rats. Protein extracts from different brain regions at different ages
were electrophoresed in denaturing polyacrylamide gels and electro-
blotted to nitrocellulose. The filters were probed with a polyclonal
antibody directed against the COOH-terminal portion of MAG.
Shown are the results obtained using three pooled samples from nor-
mal (C) or hypothyroid (H) killed at 10, 15, 20, 25, and 30 d of
postnatal age. MAG was present as a broad protein band spanning in
size from 100 to 116 kD.
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crease the intensity of a nonspecific band of 58 kD that was not
altered by hypothyroidism, and thus served as control for the
amount ofprotein loaded on the gels. In the cortex and hippo-
campus of normal rats, MAG was almost undetectable on PO0,
and was clearly present on P15. It increased subsequently
reaching high levels on P25 and P30. In striatum and mesen-
cephalon, MAG was already present on PlO, and increased
thereafter reaching maximal levels on P20-P25. There was a
clear effect of hypothyroidism in the cerebral cortex, hippo-
campus and striatum, with very low levels ofMAG up to P20
compared with normal animals. In hypothyroid animals, levels
ofMAG increased after P20 and, therefore, the differences with
normal animals tended to disappear. The effect ofhypothyroid-
ism in the mesencephalon was less evident, and there was some-
what less MAG in the hypothyroid samples of P15 and P20.
The transient effect of hypothyroidism on MAG protein was
also evident in the cerebellum, where only on P10 there was
clearly a lower amount of protein in hypothyroid rats.
Hyperthyroidism accelerates MAG mRNA expression. If
thyroid hormones are involved in the timing ofMAG expres-
sion, it is likely that contrary to the effect of hypothyroidism,
thyroid hormone excess induced a precocious expression ofthe
MAG gene. To study this possibility, normal or hypothyroid
animals were administered 5 ,ug ofT4 per rat during 5 d before
death to evaluate the effect of hyperthyroidism. MAG mRNA
was examined by Northern blotting in the striatum on day 7
and in the cerebral cortex on days 10 and 12 (Fig. 6). On day 7,
no MAG mRNA was detected in untreated normal or hypothy-
roid animals, but it was clearly present in both groups of T4-
treated rats. According to previous results, very little MAG was
also detected in the cerebral cortex on day 10 in normal ani-
mals, and again T4 treatment resulted in MAG mRNA accu-
mulation in both control and hypothyroid animals. On day 12,
MAG was already clearly expressed in the cortex of normal
rats, but was almost absent in hypothyroid animals. T4 treat-
ment increased MAG expression in both groups. These results
demonstrate that thyroid hormone excess resulted in an acceler-
ation ofMAG mRNA accumulation.
Thyroid hormones do not affect the rate oftranscription of
the MAG gene. To examine the cause of the effects of thyroid
hormone deficiency or excess, we performed run-on analyses
using nuclei from normal, hypothyroid, or T4-treated rats as
described above. The in vitro-labeled nuclear transcripts were
hybridized with full-length cDNAs encoding MAG, cyclophi-
lin as a thyroid hormone independent message, and pBR322 as
control for nonspecific hybridization. As a source of nuclei we
first used cerebral corteces of 1 2-d-old animals as in the experi-
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Figure 6. Effect of hypothyroidism on MAG mRNA accumulation.
Hypothyroid and control animals were treated (+) or untreated (-)
with a single daily dose of 5 gg T4 during the last 5 d before death.
Rats were killed at 7, 10, and 12 d and MAG mRNA was measured
by Northern blotting in striatum (7 d) or cerebral cortex ( 10 and 12 d).
ment illustrated in Fig. 6. A representative result from one of
two independent experiments is illustrated in Fig. 7 A, showing
no obvious significant differences among the three experimen-
tal groups. The mean MAG/cyclophilin ratios obtained after
densitometry for the two experiments were 1.1 (control), 1.3
(hypothyroid) and 0.8 (T4 treated). We also used nuclei from
total cerebra of 13-d-old animals, which were expected to be
more actively transcribing the MAG gene. To better quantify
the results and to correct for eventual differences in the amount
ofMAG RNA hybridized to the respective probes, we included
a [3H ]MAGmRNA in the hybridization mixture. After hybrid-
ization and exposure to x-ray films, the bands were cut out and
radioactivity was measured. The results shown in Fig. 7 B,
again did not reveal significant differences between normal and
hypothyroid animals. The signal for T4-treated animals was
slightly higher, both in the MAG probe and the CF control
probe. After quantification ofthe data, taking into account the
total amount of 32p present in the hybridization mixtures ( 1.4,
1.6, and 2.1 million cpm for control, hypothyroid, and T4
treated, respectively) and the percentage [3H ]MAG mRNA
hybridized (control = 4.27, hypothyroid = 2.52, T4 treated
= 4.07), the percent of total 32P hybridized was 0.20 (control
rats), 0.24 (hypothyroid rats), and 0.18 (T4-treated rats).
Taken together from the results of the three experiments, we
conclude that MAG mRNA changes with thyroid status were
not caused by altered MAG transcription.
Discussion
It is known that one of the most severe effects of neonatal
hypothyroidism is a lower deposition of myelin in the central
nervous system. Hypothyroid brains have decreased amounts
of cholesterol, cerebrosides, sulfatides, glycolipids, sulfolipids,
and gangliosides in the myelin sheaths ( 13-18). These effects
appear to be the consequence of decreased activities of en-
zymes involved in myelin lipid synthesis, such as cerebroside
sulfotransferase and galactosyl transferases ( 16). At present, it
is not known whether thyroid hormone controls directly the
activity of these enzymes or some other key event leading to
myelination. Myelination is a highly regulated timely event
that in the rat starts suddenly a few days after birth and depends
C H T4
A MAG
CF
pBR
B MAG
CF
pBR
Cortex
Cerebrum
Figure 7. Run-on analysis of the effect of hypothyroidism and T4
treatment on the MAG gene. Run-on analyses were performed using
nuclei from pooled (three rats per pool) cerebral cortices (A), or cere-
bra (B) ofnormal, hypothyroid or T4 treated rats as described above.
Cortex nuclei were from 1 2-d-old animals and cerebral nuclei from
1 3-d-old animals. As probes we used MAG, cyclophilin (CS), and
pBR322. No hybridization was obtained using nuclei transcribed in
the presence of alpha-amanitin (not shown).
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on the proper differentiation of oligodendrocytes from its 02A
precursor cells. Oligodendrocyte differentiation is determined
by the concerted actions of fibroblast and platelet-derived
growth factors (39). As shown in this paper, thyroid hormone
is also required for full expression of at least one of the differen-
tiated properties of oligodendrocytes; i.e. expression of the
MAG gene, and its main role is to ensure an accurate timing of
gene expression.
Hypothyroidism led to a delay in the pattern ofMAG accu-
mulation in different brain regions. The regional effect of hypo-
thyroidism reflects the fact that myelination does not proceed
simultaneously throughout the brain. Normally, the myelina-
tion wave starts in caudal regions and proceeds towards rostral
areas. This pattern has been deduced from studies of myelin
mRNA accumulation by either Northern blots or in situ hybrid-
ization (38). We show here that regions that myelinate last are
more affected by hypothyroidism than those of earlier myelina-
tion. From the patterns of expression of MAG mRNA or pro-
tein, we conclude that caudal regions such as cerebellum, hypo-
thalamus, and mesencephalon present a transient alteration
with spontaneous recovery beyond days 15-20 after birth. This
pattern is similar to the effect of hypothyroidism on microtu-
bule-associated protein-2 in the cerebellum (40). In contrast,
normalization in the hippocampus and striatum did not occur
before days 25-30, and myelination in the cerebral cortex was
impaired beyond the first month of life.
The timing control by thyroid hormone is also supported
by the effect of hyperthyroidism. In the presence ofan excess of
thyroid hormone, MAG expression was accelerated in previ-
ously normal or hypothyroid animals. This is in agreement
with other results reporting an acceleration of myelination in
hypothyroid rats, with precocious increases of myelin enzyme
activities (41 ). A clear timing control by thyroid hormone also
occurs during cerebellar development (42), in the transition
between the juvenile and adult forms of Tau (43), in the ex-
pression of neuronal markers such as synapsin I in culture
(44), during development of the organ of Corti (45), or in the
appearance ofenzymes during development ofcholinergic neu-
rons (46).
The action of thyroid hormone on MAG expression could
be exerted directly by the interaction of the thyroid hormone
receptor with promoter sequences in the MAG gene. Although
we have detected no labeling in white matter by in situ hybrid-
ization using c-erbA probes ( 11 ), oligodendrocytes in primary
cultures have been shown to express the thyroid hormone re-
ceptor (47). T3 receptors have recently been demonstrated in
glial cells isolated from rat brain during the neonatal period
(48). Highest receptor density was found in the cerebral cortex.
The rest of brain regions contained much fewer amounts of
receptor and, contrary to the cortex, receptor density declined
during development, especially in the cerebellum. These data
agree with the transient dependency ofmyelin genes during the
early stages of myelination reported in this paper. Recently,
Nikodem and associates have described the presence of se-
quences in the promoter region of myelin basic protein that
have functional characteristics of a thyroid hormone respon-
sive element ( 19). In contrast, we find that neither hypothy-
roidism nor thyroid hormone treatment modified significantly
the rates oftranscription ofthe MAG gene. Therefore, hypothy-
roidism could have led to a decreased stability of MAG
mRNA. An increased degradation in the presence of an equal
rate of synthesis would be predicted to result in a delay of
mRNA accumulation. Others have also shown an effect of thy-
roid hormone on MBP gene expression in aggregating brain
cell cultures, which is mediated through an action on mRNA
stability rather than transcription (20). The fact that the rate of
transcription was not modified is also an argument against a
possible effect on the number of oligodendrocytes, which is in
agreement with the known lack ofeffect ofthyroid hormone on
oligodendrocyte proliferation (49). Other reports have also
suggested that the number ofoligodendrocytes does not change
in hypothyroidism (50). Although an effect on mRNA trans-
port from the nucleus to the cytoplasm cannot be discarded at
present, it is likely that thyroid hormone is required to stabilize
newly transcribed MAG mRNA during the earlier phases of
myelination to allow for a rapid accumulation of the tran-
scripts and protein production. This is not surprising, in view
of the fact that although the main control on myelin gene ex-
pression is exerted at the level of transcription by oligodendro-
cyte-specific transcription factors (21-24), there is also control
at the posttranscriptional level. For example, glucocorticoids
posttranscriptionally regulate the expression of basic protein
and proteolipid protein (5 1 ). The deficits ofmyelination ofthe
myelin deficient mice (mid) are also caused by posttranscrip-
tional events (52).
As we have shown previously ( 12), other oligodendrocyte
specific genes as MBP and proteolipid protein are also affected
by neonatal hypothyroidism. The question arises as to whether
thyroid hormone influences the expression ofeach myelin gene
by a similar mechanism, or the effects are the end result of the
regulation of an as yet unidentified key developmental gene
that could be influenced by thyroid hormone itself, or by thy-
roid hormone-dependent factors, including growth hormone.
Whether thyroid hormone acts directly or indirectly, its effect
on the expression ofMAG would be critical early in myelina-
tion. Because of its cell-adhesion properties, its localization in
the periaxonal space and uncompacted myelin, and its timing
of expression in relation to other myelin proteins (53), MAG
has been proposed to establish initial interactions between the
oligodendrocyte surface and the axon to be myelinated, and in
the maintenance of this interaction.
Independently ofthe mechanism ofaction, a delay ofmyeli-
nation, even iftransient, would result in serious disturbances of
brain maturation, since the normal coordination between axon
growth and targeting and myelination will not occur. The al-
tered pattern of myelination should have profound conse-
quences on the hypothyroid brain in terms of neuron perfor-
mance and development of fiber networks. In addition to its
role in myelination, MAG has also neurite outgrowth activity
(54), an impairment of which would constitute an additional
factor contributing to the complexity and severity of the hypo-
thyroid brain phenotype.
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